Belgian Pharma Stock News

Agfa-Gevaert NV recently reported its third quarter 2025 earnings, revealing sales of €257 million and a net loss of €19 million, both down compared to the same period last year. Although the company's nine-month net loss improved versus the previous year, the quarterly results point to continued operational headwinds affecting Agfa-Gevaert's performance. We'll explore how the combination of declining quarterly sales and a widening net loss is shaping Agfa-Gevaert's investment narrative. AI...

Retail Estates N.V. recently reported earnings for the half year ended September 30, 2025, with sales of €72.84 million and net income of €47.15 million, both up from the same period last year. This higher net income suggests operational gains that may draw attention to the company's performance in the retail property sector. We'll explore how the improvement in net income highlights Retail Estates' current investment narrative and outlook within its market segment. Uncover the next big...

Earlier this month, Barco announced the expansion of its strategic ClickShare partnerships with Sennheiser, Logitech, and Huddly, aiming to deliver integrated, high-performance meeting room solutions through certified room system bundles built around the new ClickShare Hub. This collaboration leverages advanced audio and video technologies to strengthen Barco's position in the wireless BYOD and meeting room systems market, facilitating broader adoption of its solutions in diverse meeting...

NV Bekaert (ENXTBR:BEKB) just announced a partnership with EMSTEEL to develop sustainable steel products and solutions using UAE-made steel. The collaboration covers technical cooperation and aims to expand offerings across Gulf markets. See our latest analysis for NV Bekaert. Bekaert’s recent partnership news comes after a steady period for its stock, with year-to-date share price gains of 3.57% and a solid 12.82% total shareholder return over the past year. Despite some short-term...

As European markets navigate a landscape shaped by mixed economic indicators and cooling sentiment on artificial intelligence, the pan-European STOXX Europe 600 Index has shown resilience with a 1.77% increase, buoyed by relief over the U.S. government reopening. In this climate of cautious optimism, identifying promising small-cap stocks requires a keen eye for companies that demonstrate strong fundamentals and adaptability to shifting market dynamics.

Cenergy Holdings reported third-quarter and nine-month 2025 results, delivering sales of €524.27 million and €1.55 billion, and net income of €52.43 million and €147.69 million, respectively, both up from the prior year. Sales and net income growth outpaced the previous year's comparable periods, suggesting the company's operations benefited from strong demand and improved profitability. We'll take a closer look at how Cenergy Holdings' strong revenue and earnings growth this quarter informs...

While D'Ieteren Group SA ( EBR:DIE ) shareholders are probably generally happy, the stock hasn't had particularly good...

Belgian holding company GBL recently sold half its stake in Umicore through an accelerated bookbuild, reducing its ownership from 16% to 8% and committing to a 90-day lock-up on its remaining shares. This transaction reflects GBL’s broader plan to streamline its portfolio towards private assets and follows a period of recovery for Umicore’s share price. We'll assess how GBL's sizable stake reduction impacts Umicore’s investment outlook and potential capital structure considerations going...

It is hard to get excited after looking at Ackermans & Van Haaren's (EBR:ACKB) recent performance, when its stock has...

As an investor its worth striving to ensure your overall portfolio beats the market average. But the risk of stock...

As European markets show resilience with the STOXX Europe 600 Index gaining 1.77% amidst global economic shifts, investors are increasingly looking towards small-cap stocks for potential opportunities, especially as cooling sentiment on artificial intelligence tempers broader market enthusiasm. In this environment, identifying stocks with strong fundamentals becomes crucial, as these attributes can provide stability and growth potential even when broader market conditions fluctuate.

Azelis Group (ENXTBR:AZE) shares have recently caught the attention of market watchers, with moves in the stock price reflecting a broader pattern in the specialty chemicals sector. Trading activity suggests investors are weighing up the company’s most recent business fundamentals. See our latest analysis for Azelis Group. Azelis Group’s 1-year total shareholder return of -48.71% reflects a tough stretch for the business, with momentum clearly fading as the stock’s YTD share price return sits...

argenx (ENXTBR:ARGX) stock has gained fresh attention from investors recently, and its movement stands out when you look at how it has performed over the past month and past 3 months. The company’s trajectory offers some interesting discussion points for those interested in the biotech sector. See our latest analysis for argenx. argenx has captured attention with a 40% 90-day share price return and a strong 48% total shareholder return over the last year, reflecting renewed investor optimism...

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...

Solvay (ENXTBR:SOLB) just inked a supply agreement with Noveon Magnetics, setting the stage for delivery of rare earth oxides starting in 2026. This collaboration aims to create a sustainable supply chain for critical magnet materials in the context of ongoing supply challenges. See our latest analysis for Solvay. After a tough start to the year, Solvay’s share price has slipped 11.1% year-to-date, reflecting shifting investor sentiment despite big moves like the Noveon deal and steady...

Key Insights The projected fair value for Melexis is €54.64 based on 2 Stage Free Cash Flow to Equity With €55.65 share...

Anheuser-Busch InBev (ENXTBR:ABI) shares have climbed almost 5% over the past month, catching the interest of investors looking for momentum. The company’s improving financials add another factor for anyone watching food and beverage stocks right now. See our latest analysis for Anheuser-Busch InBev. Momentum appears to be building for Anheuser-Busch InBev, with the share price jumping more than 12% year-to-date and a 1-year total shareholder return of just over 4%. While recent financial...

KBC Group NV reported third quarter and nine-month earnings for the period ended September 30, 2025, with net income rising to €1.00 billion for the quarter and €2.57 billion for the nine months, both higher than the same periods last year. The company's earnings per share from continuing operations also increased over both periods, reflecting improved profitability and operational performance. We'll assess how the jump in net income and earnings per share informs KBC Group's ongoing...

Noveon Magnetics and Solvay recently announced a multi-year supply agreement for light and heavy rare earth oxides, with Solvay providing Neodymium-Praseodymium, Dysprosium, and Terbium oxides, sourced partly from recycled materials, to support Noveon's production of permanent magnets starting in 2026. This collaboration advances a more resilient and sustainable domestic supply chain for rare earth magnets amid ongoing global supply risks and growing demand. The agreement enhances Solvay's...

argenx SE recently received Health Canada approval for VYVGART SC as a monotherapy for adult patients with active chronic inflammatory demyelinating polyneuropathy (CIDP), making it the first innovative CIDP treatment option in Canada in over 30 years and the first FcRn blocker approved for this use. The once-weekly, subcutaneous self-administration of VYVGART SC presents a new level of flexibility and convenience for patients while potentially reducing demand for human-derived blood...

Campine NV ( EBR:CAMB ) shares have had a horrible month, losing 26% after a relatively good period beforehand. Of...

It's not a stretch to say that Azelis Group NV's ( EBR:AZE ) price-to-earnings (or "P/E") ratio of 14x right now seems...

On October 31, 2025, Cmb.Tech NV was removed from the Euronext 150 Index, an important benchmark for European equities. Such index exclusions can lead to substantial portfolio adjustments by institutional investors, as many funds track or benchmark to major indices. We'll explore how Cmb.Tech's index removal could reshape its investment narrative, especially given potential shifts in institutional ownership. We've found 14 US stocks that are forecast to pay a dividend yield of over 6% next...

UCB (ENXTBR:UCB) received FDA approval for KYGEVVI, marking a major step in rare disease treatment. KYGEVVI is the first approved therapy for TK2d, a life-threatening mitochondrial disorder with very limited options. See our latest analysis for UCB. Following the FDA approval for KYGEVVI, UCB's momentum has been building. The share price has climbed nearly 20% year-to-date. After some short-term volatility, the stock's 1-year total shareholder return stands at an impressive 26%. Those who...